These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

961 related articles for article (PubMed ID: 2936813)

  • 1. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
    Roberts LK
    J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of a continuous T cell line capable of suppressing anti-tumor immune responses in vivo.
    Roberts LK; Spellman CW; Warner NL
    J Immunol; 1983 Jul; 131(1):514-9. PubMed ID: 6223081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Origin and characteristics of ultraviolet-B radiation-induced suppressor T lymphocytes.
    Shreedhar VK; Pride MW; Sun Y; Kripke ML; Strickland FM
    J Immunol; 1998 Aug; 161(3):1327-35. PubMed ID: 9686595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
    Chen PW; Kaba DS; Ananthaswamy HN
    Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
    Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
    Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms in the suppression of tumor rejection produced in mice by repeated UV irradiation.
    Ullrich SE; Kripke ML
    J Immunol; 1984 Nov; 133(5):2786-90. PubMed ID: 6237155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor T cell circuits in contact sensitivity. III. A monoclonal T cell hybrid-derived suppressor factor specifically suppresses local DTH transfer by a DNP-specific T cell clone.
    Miller SD; Jenkins MK
    J Immunol; 1986 Mar; 136(5):1571-8. PubMed ID: 2419406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH; Gurish MF; Daynes RA
    Immunology; 1982 Sep; 47(1):49-59. PubMed ID: 6981587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo.
    Hostetler LW; Romerdahl CA; Kripke ML
    Cancer Res; 1989 Mar; 49(5):1207-13. PubMed ID: 2465081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor cell clones specific for ultraviolet radiation-induced tumors. Function and surface proteins.
    Trial J; McIntyre BW
    J Immunol; 1990 Oct; 145(7):2044-9. PubMed ID: 1975821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of helper T-lymphocytes in rejection of UV-induced murine skin cancers.
    Romerdahl CA; Kripke ML
    Cancer Res; 1988 May; 48(9):2325-8. PubMed ID: 2965612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic epidermal T cells in ultraviolet-irradiated skin enhance skin tumor growth by inhibiting CD4+ T-cell-mediated immunity.
    Cavanagh LL; Halliday GM
    Cancer Res; 1996 Jun; 56(11):2607-15. PubMed ID: 8653705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the immune response against UV-induced skin cancers: specificity of helper cells and their susceptibility to UV-induced suppressor cells.
    Romerdahl CA; Kripke ML
    J Immunol; 1986 Nov; 137(9):3031-5. PubMed ID: 2944968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential antigen presentation in tumor immunity.
    Schatten S; Drebin JA; Granstein RD; Greene MI
    Fed Proc; 1984 Jun; 43(9):2460-4. PubMed ID: 6327399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of antigenic variants from a nonantigenic murine tumor cell line by transfection with a gene encoding a novel tumor-specific transplantation antigen.
    Kaba DS; McIntyre BW; Kripke ML; Goodenow RS; Schreiber H; Ananthaswamy HN
    Cancer Res; 1989 Jan; 49(1):38-43. PubMed ID: 2783244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
    Streilein JW; Niederkorn JY
    J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.